Delivery Order SPE2DB22D3004-SPE2DB25FPK42

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,653.45, is for the provision of Wegovy 1 mg/0.5 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
This is a $1,228.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of the drug Wegovy 0.5 mg/0.5 ml pen, 0.5 ml, with a period of performance through January 27, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,334.92 firm-fixed-price contract is for the provision of Wegovy 0.5 mg/0.5 ml pens. The ultimate completion date is November 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,210.60, is for the supply of the prescription medication Wegovy 0.5 mg/0.5 ml pen with an ultimate completion date of March 29, 2023. The contract is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,738.96 firm fixed-price delivery order is for the supply of Wegovy 1 mg/0.5 ml pens, with an ultimate completion date of October 18, 2024. The contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $24,430.41 and is for the supply of the drug Wegovy 0.5 mg/0.5 ml pen with a completion date of February 5, 2025. This award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 1 mg/0.5 ml pens. The contract has a ceiling value of $2,016.90 and a completion date of May 5, 2023. It is a firm fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Wegovy 1 mg/0.5 ml pens, with a ceiling value of $20,173.49 and a period of performance through November 14, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,251.41, is a delivery order for the medication Wegovy 0.5 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price contract with a completion date of February 13, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 1 mg/0.5 ml pen, a prescription medication. The $11,874.60 firm-fixed-price contract has a completion date of September 5, 2024. As a delivery order, this award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPK42
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,685.50, is for the delivery of Wegovy 0.5 mg/0.5 ml pens. The contract has an ultimate completion date of February 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/7/25, 10:04 AM